AstraZeneca buying drug developer in £30bn deal
Published
Pharmaceutical giant AstraZeneca is to buy US drug developer Alexion in a deal worth almost £30 billion.
Full ArticlePublished
Pharmaceutical giant AstraZeneca is to buy US drug developer Alexion in a deal worth almost £30 billion.
Full ArticlePharmaceutical giant AstraZeneca has said it is buying a US drug company in a deal worth 39 billion US dollars (£29 billion).